Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 12 | SFE2006 | Next issue

197th Meeting of the Society for Endocrinology

Poster Presentations

Cytokines, growth factors, growth and development

ea0012p33 | Cytokines, growth factors, growth and development | SFE2006

Effects of recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3) on human malignant pleural mesothelioma cell growth

Miraki-Moud F , Martinelli C , Camacho-Hübner C

Malignant pleural mesothelioma (MPM) is an asbestos-related tumour which is highly resistant to standard treatments, thus continuing to present a therapeutically challenge. Insulin-like growth factor system (IGFs), play an important role in the regulation of solid tumour cell growth. IGFBP-3, the most abundant circulating IGF binding protein, inhibits cell growth by both IGF-I dependent and independent pathways.The aim of our study was to evaluate the ef...

ea0012p34 | Cytokines, growth factors, growth and development | SFE2006

Quantitative RT-PCR (qRT-PCR) as an early stage bioassay for vascular endothelial growth factor (VEGF)

Burns CJ , Robinson CJ

The objective of this study is to investigate the use of qRT-PCR as an early-stage bioassay to quantify biological activity. The action of VEGF165 on human umbilical vein endothelial cells (HUVECs) was selected as a model since we have previously studied dose-dependence and time courses for several late-stage responses for this system (production of IL-6, IL-8 and tissue factor, cellular proliferation and survival). Assay of VEGF activity and inhibitors underpins a ...

ea0012p35 | Cytokines, growth factors, growth and development | SFE2006

Effects of androgens on differentiation of human skeletal muscle-derived cells in vitro

Solomon AM , Sinanan ACM , Bouloux PMG , Lewis MP

IntroductionThe mechanism by which hypertrophy of skeletal muscle occurs in response to anabolic androgens is incompletely understood. This study used a cell culture model of human skeletal muscle-derived cells, with samples obtained from consenting subjects and local ethics committee approval. The objective was to determine changes in myogenicity upon exposure to exogenous androgen +/− IGF-1 and to see whether an additive effect would be observed....